NCT00564889View on ClinicalTrials.gov

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

June 30, 2012

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

cyclophosphamide

300 mg/m\^2 days 1, 8 \& 15 of a 28 day cycle taken orally with food

DRUG

dexamethasone

40 mg weekly taken orally

DRUG

lenalidomide

15 mg daily days 1-21 of a 28 day cycle taken orally with food

Trial Locations (3)

32224

Mayo Clinic in Florida, Jacksonville

55905

Mayo Clinic, Rochester

85259-5499

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER